See more : DAIHEN Corporation (6622.T) Income Statement Analysis – Financial Results
Complete financial analysis of Toyobo Co., Ltd. (TYOBY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Toyobo Co., Ltd., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- BlueRiver Acquisition Corp. (BLUA-WT) Income Statement Analysis – Financial Results
- Wirtek A/S (WIRTEK.CO) Income Statement Analysis – Financial Results
- Gold Reserve Inc. (GRZ.V) Income Statement Analysis – Financial Results
- NBT Bancorp Inc. (NBTB) Income Statement Analysis – Financial Results
- Mesoblast Limited (MSB.AX) Income Statement Analysis – Financial Results
Toyobo Co., Ltd. (TYOBY)
About Toyobo Co., Ltd.
Toyobo Co., Ltd. provides films and functional polymers, industrial materials, and healthcare and textile products worldwide. It offers industrial films, including PET films for liquid crystal display, optical, and other industrial use; and synthetic papers. The company also provides packaging films, such as PET, polyolefin, and nylon for food packaging, as well as heat-shrink PET films; functional polymers comprising engineering plastics, industrial adhesives, coatings, photo-sensitive printing plates, acrylate polymers, and electronic materials; rubber and coat processing; and pharmaceuticals intermediates. In addition, it offers functional fibers consisting of airbag fabrics; polyethylene and PBO fibers; functional filters for automobiles, indoor, and anti-pollution solvent adsorption materials and units; and fiber materials for automobile parts. Further, the company provides bio products, including enzymes for diagnostics, diagnostic systems, and reagents for research; artificial kidney hollow fibers; anti-clotting materials; seawater desalination modules; functional textiles for sports clothing, underwear, and uniforms; synthetic filaments; apparel under the Munsingwear brand; acrylic fibers under the Exlan brand; and acrylate fibers under the eks brand, as well as trades in textile products. Additionally, it operates as a contract manufacturer of injections. The company was founded in 1882 and is headquartered in Osaka, Japan.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 414.27B | 399.92B | 375.72B | 337.41B | 339.61B | 336.70B | 331.15B | 329.49B | 347.76B | 351.28B | 351.58B | 339.01B |
| Cost of Revenue | 326.27B | 314.92B | 279.59B | 247.03B | 255.14B | 255.56B | 249.94B | 249.81B | 267.94B | 274.50B | 274.60B | 267.69B |
| Gross Profit | 88.00B | 85.01B | 96.13B | 90.37B | 84.47B | 81.14B | 81.21B | 79.68B | 79.83B | 76.78B | 76.98B | 71.32B |
| Gross Profit Ratio | 21.24% | 21.26% | 25.58% | 26.78% | 24.87% | 24.10% | 24.52% | 24.18% | 22.95% | 21.86% | 21.89% | 21.04% |
| Research & Development | 15.31B | 14.11B | 13.79B | 12.66B | 11.69B | 11.02B | 10.40B | 11.11B | 11.27B | 10.82B | 10.47B | 9.97B |
| General & Administrative | 50.40B | 47.18B | 40.62B | 39.27B | 38.36B | 37.45B | 36.43B | 35.94B | 35.76B | 35.27B | 35.65B | 34.37B |
| Selling & Marketing | 13.21B | 13.75B | 13.37B | 11.87B | 11.70B | 10.94B | 10.46B | 9.30B | 9.68B | 10.29B | 9.99B | 10.04B |
| SG&A | 63.61B | 60.93B | 53.99B | 51.14B | 50.06B | 48.39B | 46.89B | 45.24B | 45.44B | 45.55B | 45.64B | 44.41B |
| Other Expenses | 82.00M | -3.50B | -5.61B | -5.59B | -5.11B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 79.00B | 74.94B | 67.70B | 63.72B | 61.67B | 59.42B | 57.29B | 56.35B | 56.71B | 63.29B | 62.10B | 57.51B |
| Cost & Expenses | 405.27B | 389.86B | 347.29B | 310.75B | 316.81B | 314.97B | 307.23B | 306.16B | 324.64B | 337.79B | 336.70B | 325.20B |
| Interest Income | 0.00 | 1.01B | 680.00M | 728.00M | 719.00M | 563.00M | 603.00M | 832.00M | 914.00M | 1.17B | 1.01B | 1.04B |
| Interest Expense | 1.36B | 1.33B | 1.21B | 1.28B | 1.37B | 1.31B | 1.27B | 1.41B | 1.62B | 1.79B | 1.58B | 2.93B |
| Depreciation & Amortization | 19.81B | 19.05B | 20.08B | 19.10B | 17.01B | 15.94B | 15.90B | 15.15B | 14.67B | 14.50B | 12.61B | 12.30B |
| EBITDA | 26.75B | 29.11B | 48.51B | 45.75B | 39.80B | 37.67B | 39.82B | 38.48B | 37.79B | 35.08B | 33.61B | 29.38B |
| EBITDA Ratio | 6.46% | 6.68% | 11.78% | 12.07% | 10.54% | 11.19% | 12.02% | 11.68% | 10.87% | 9.99% | 9.56% | 8.67% |
| Operating Income | 9.00B | 10.06B | 28.43B | 26.66B | 22.79B | 21.73B | 23.92B | 23.33B | 23.12B | 20.58B | 21.01B | 17.08B |
| Operating Income Ratio | 2.17% | 2.52% | 7.57% | 7.90% | 6.71% | 6.45% | 7.22% | 7.08% | 6.65% | 5.86% | 5.98% | 5.04% |
| Total Other Income/Expenses | -3.41B | -9.45B | -13.63B | -21.08B | -3.08B | -21.63B | -5.70B | -9.39B | -6.90B | -8.26B | -7.14B | -4.31B |
| Income Before Tax | 5.59B | 612.00M | 14.80B | 5.58B | 19.72B | 102.00M | 18.23B | 13.94B | 16.22B | 12.32B | 13.87B | 12.77B |
| Income Before Tax Ratio | 1.35% | 0.15% | 3.94% | 1.65% | 5.81% | 0.03% | 5.50% | 4.23% | 4.67% | 3.51% | 3.95% | 3.77% |
| Income Tax Expense | 2.01B | 1.42B | 2.74B | 3.27B | 6.41B | 913.00M | 5.24B | 4.91B | 5.96B | 4.02B | 4.72B | 4.40B |
| Net Income | 2.46B | -655.00M | 12.87B | 4.20B | 13.77B | -603.00M | 13.04B | 9.44B | 10.15B | 8.12B | 8.15B | 7.64B |
| Net Income Ratio | 0.59% | -0.16% | 3.42% | 1.25% | 4.06% | -0.18% | 3.94% | 2.87% | 2.92% | 2.31% | 2.32% | 2.25% |
| EPS | 27.87 | -7.37 | 144.75 | 47.30 | 155.12 | -6.79 | 146.92 | 106.38 | 114.33 | 91.42 | 91.77 | 86.13 |
| EPS Diluted | 27.87 | -7.37 | 144.75 | 47.30 | 155.12 | -6.79 | 146.92 | 106.38 | 114.33 | 91.42 | 91.77 | 86.13 |
| Weighted Avg Shares Out | 88.10M | 88.89M | 88.88M | 88.83M | 88.79M | 88.77M | 88.77M | 88.78M | 88.78M | 88.79M | 88.85M | 88.70M |
| Weighted Avg Shares Out (Dil) | 88.10M | 88.89M | 88.88M | 88.83M | 88.79M | 88.77M | 88.77M | 88.78M | 88.78M | 88.79M | 88.85M | 88.70M |
Source: https://incomestatements.info
Category: Stock Reports